Ionis Pharmaceuticals Inc (IONS) — Cash Flow Reinvestment Rate
Ionis Pharmaceuticals Inc (IONS) has a Cash Flow Reinvestment Rate of 0.89x as of June 2025, reinvesting $134.34 Million (capex $14.27 Million plus investments $-120.07 Million) from operating cash flow of $151.34 Million. Check earnings quality score of Ionis Pharmaceuticals Inc to evaluate the quality of earnings relative to operating cash generation.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Ionis Pharmaceuticals Inc Cash Flow Reinvestment Rate (2007–2021)
Historical reinvestment intensity for Ionis Pharmaceuticals Inc across 11 annual periods. Explore Ionis Pharmaceuticals Inc long-term investment intensity to see how much of total assets are deployed in long-term investments.
Annual Cash Flow Reinvestment Rate for Ionis Pharmaceuticals Inc (2007–2021)
Year-by-year capital reinvestment analysis for Ionis Pharmaceuticals Inc. For live market cap and broader valuation context, see IONS market cap.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2021 | 7.49x | $230.71 Million | $30.80 Million | $17.90 Million | ▼ -24.6% |
| 2020 | 9.93x | $356.57 Million | $35.89 Million | $41.05 Million | ▲ +8221.4% |
| 2019 | 0.12x | $41.27 Million | $345.72 Million | $36.28 Million | ▼ -92.3% |
| 2018 | 1.54x | $929.56 Million | $602.89 Million | $17.65 Million | ▼ -25.1% |
| 2017 | 2.06x | $358.29 Million | $174.15 Million | $37.86 Million | ▼ -27.7% |
| 2015 | 2.85x | $60.10 Million | $21.12 Million | $11.75 Million | ▼ -79.0% |
| 2014 | 13.57x | $85.31 Million | $6.29 Million | $11.10 Million | ▲ +233.8% |
| 2013 | 4.07x | $258.15 Million | $63.49 Million | $5.36 Million | ▼ -74.5% |
| 2012 | 15.97x | $29.95 Million | $1.88 Million | $5.17 Million | ▲ +19735.1% |
| 2008 | 0.08x | $17.07 Million | $212.03 Million | $17.07 Million | ▼ -42.0% |
| 2007 | 0.14x | $5.01 Million | $36.09 Million | $5.01 Million | — |